Successful short-term and long-term treatment of melasma and postinflammatory hyperpigmentation using vitamin C with a full-face iontophoresis mask and a mandelic/malic acid skin care regimen

Journal of Drugs in Dermatology

Volumn 12, Issue 1, 2013, Pages 45-50

  Taylor, Mark B ^a   Yanaki, Jamal S ^b   Draper, David O ^c   Shurtz, Joe C ^c   Coglianese, Mark ^c  

^a Gateway Aesthetic Institute and Laser Center   (United States)

^b ActivaTek Inc   (United States)

^c BRIGHAM YOUNG UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; MALIC ACID; MANDELIC ACID;

ADULT; AGED; ARTICLE; CHLOASMA; CLINICAL ARTICLE; FOLLOW UP; FULL FACE IONTOPHORESIS MASK; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MASK; POSTINFLAMMATORY HYPERPIGMENTATION; SKIN CARE; SKIN PENETRATION; TREATMENT RESPONSE; WRINKLE;

ADULT; ASCORBIC ACID; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERPIGMENTATION; IONTOPHORESIS; MALATES; MALE; MANDELIC ACIDS; MASKS; MELANOSIS; MIDDLE AGED; SKIN; SKIN ABSORPTION; SUNSCREENING AGENTS; TREATMENT OUTCOME; VITAMINS;

EID: 84873479234     PISSN: 15459616     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Pathak MA, Riley FC, Fitzpatrick TB. Melanogenesis in human skin following exposure to long-wave ultraviolet and visible light. J Invest Dermatol. 1962;39:435-443.
2. Mahmoud BH, Ruvolo E, Nexsel CL, et al. Impact of long-wavelength UVA and visible light on melanocompetent skin. Poster presented at: 2008 American Society for Laser Medicine and Surgery Annual Meeting; April 2-6, 2008; Kissimmee, FL.
3. Sharquie KE, Al-Tikreety MM, Al-Mashhadani SA. Lactic acid as a new therapeutic peeling agent in melasma. Dermatol Surg. 2005;31(2):149-154.
4. Faghihi G, Shahingohar A, Siadat AH. Comparison between 1% tretinoin peeling versus 70% glycolic acid peeling in the treatment of female patients with melasma. J Drugs Dermatol. 2011;10(12):1439-1442.
5. Mahmoud BH, Nexsel CL, Hamzavi IH, Lim HW. Effects of visible light on the skin. Photochem Photobiol. 2008;84(2):450-462.
6. Sheth VM, Pandya AG. Melasma: a comprehensive update: part I. J Am Acad Dermatol. 2011;65(4):689-697.
7. Sheth VM, Pandya AG. Melasma: a comprehensive update: part II. J Am Acad Dermatol. 2011;65(4):699-714.
8. Lakhdar H, Zouhair K, Khadir K, et al. Evaluation of the effectiveness of broadspectrum sunscreen in the prevention of chloasma in pregnant women. J Eur Acad Dermatol Venereol. 2007;21(6):738-742.
9. Khadir K, Amal S, Hafi F, et al. Les signes dermatologiques physiologiques de la grossesse [in French]. Ann Dermatol Venereol. 1999;126:15-19.
10. Woolery-Lloyd H, Kammer JN. Treatment of hyperpigmentation. Semin Cutan Med Surg. 2011;30(3):171-175.
11. Lawrence N, Bligard CA, Reed R, Perret WJ. Exogenous ochronosis in the United States. J Am Acad Dermatol. 1988;18(5 Pt 2):1207-1211.
12. Draelos ZD. Skin lightening preparations and the hydroquinone controversy. Dermatol Ther. 2007;20(5):308-313.
13. Comeau M, Brummett R. Anesthesia of the human tympanic membrane by iontophoresis of a local anesthetic. Laryngoscope. 1978;88(2 Pt 1):277-285.
14. Glass JM, Stephen RL, Jacobson SC. The quantity and distribution of radiolabeled dexamethasone delivered to tissue by iontophoresis. Int J Dermatol. 19(9):519-525.
15. Scientific Evidence page. http://www.activatekinc.com/technology/ scientificevidence. Accessed August 2008.
16. Choi YK, Rho YK, Yoo KH, et al. Effects of vitamin C vs. multivitamin on melanogenesis; comparative study in vitro and in vivo. Int J Dermatol. 2010;49(2):218-226.
17. Huh CH, Seo KI, Park JY, Lim JG, Eun HC, Park KC. A randomized, double-blind, placebo-controlled trial of vitamin C iontophoresis in melasma. Dermatology. 2003;206(4):316-320.
18. Tung RC, Bergfeld WF, Vidimos AT, Remzi BK. alpha-Hydroxy acid-based cosmetic procedures. Guidelines for patient management. Am J Clin Dermatol. 2000;1(2):81-88.
19. Pérez-Bernal A, Muñoz-Pérez MA, Camacho F. Management of facial hyperpigmentation. Am J Clin Dermatol. 2000;1(5):261-268.
20. Kimbrough-Green CK, Griffiths CE, Finkel LJ, et al. Topical retinoic acid (tretinoin) for melasma in black patients. A vehicle-controlled clinical trial. Arch Dermatol. 1994;130(6):727-733.
21. Torok H, Taylor S, Baumann L, et al. A large 12-month extension study of an 8-week trial to evaluate the safety and efficacy of triple combination (TC) cream in melasma patients previously treated with TC cream or one of its dyads. J Drugs Dermatol. 2005;4(5):592-597.